K202343: MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL ) (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K202343 (MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL ), cleared 2020-11-16 for Beckman Coulter, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K202343
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK202343
Cleared Device Trade / Generic NameMicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL )
FDA Applicant on FilingBeckman Coulter, Inc.
FDA 3-Letter Product ClassificationProduct Code LTT
FDA Substantial Equivalence Decision Date2020-11-16
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Danaher Diagnostics across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Beckman Coulter, Inc., compare peer devices under FDA Product Code LTT, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.